1. Clinicopathological Study of Primary Intraosseous Squamous Cell Carcinoma of the Jaw and a Review of the Literature.
- Author
-
Naruse T, Yanamoto S, Sakamoto Y, Ikeda T, Yamada SI, and Umeda M
- Subjects
- Aged, Aged, 80 and over, Carcinoma, Squamous Cell mortality, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell surgery, Female, Follow-Up Studies, Humans, Male, Mandibular Neoplasms mortality, Mandibular Neoplasms pathology, Mandibular Neoplasms surgery, Maxillary Neoplasms mortality, Maxillary Neoplasms pathology, Maxillary Neoplasms surgery, Middle Aged, Odontogenic Tumors mortality, Odontogenic Tumors pathology, Odontogenic Tumors surgery, Prognosis, Retrospective Studies, Survival Analysis, Treatment Outcome, Carcinoma, Squamous Cell diagnosis, Mandibular Neoplasms diagnosis, Maxillary Neoplasms diagnosis, Odontogenic Tumors diagnosis
- Abstract
Purpose: Primary intraosseous squamous cell carcinoma (PIOSCC) is a rare malignant odontogenic tumor that originates from odontogenic epithelial remnants. It is often difficult to diagnose PIOSCC definitively; hence, extraction or surgical treatment is performed before the initial diagnosis in most cases. The present study examined new insights into and prognostic factors of patients with PIOSCC admitted to the authors' department., Materials and Methods: An extensive record review was conducted of patients who underwent radical surgery for PIOSCC from January 2001 through December 2014., Results: Of all cases of OSCC, the frequency of PIOSCC was 1.45%. The 2-year relapse-free survival (RFS) and overall survival (OS) rates were 50.0 and 41.6% in all cases, respectively. Three patients underwent surgery or tooth extraction before the initial diagnosis; in fact, intervention before initial diagnosis was found to be an important poor prognostic factor for RFS and OS. In contrast, patients who were not treated before the initial diagnosis was made did not exhibit any locoregional recurrence., Conclusions: The treatment of PIOSCC should be similar to that for oral cancer with at least clinical stage T3N0 in the National Comprehensive Cancer Network clinical practice guidelines. In addition, cases of PIOSCC that are not treated before the initial diagnosis are more likely to obtain a good prognosis., (Copyright © 2016 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF